- ►diabetesjournals.org J Chen, RP Wildman, LL Hamm, P Muntner, K … - Diabetes Care, 2004 - Am Diabetes Assoc Clinical and epidemiological data indicate that inflammation may be associated
with insulin resistance. We examined the association between inflammatory
markers, such as ferritin, uric acid, white cell counts, fibrinogen, and C- ... Cited by 45 - Related articles - BL Direct - All 5 versions
F Lainé, Y Deugnier - Gastroenterology, 2006 - Elsevier We have previously reported 2 that, in detected C282Y homozygotes, excess body
weight was commonly associated with the lack of phenotypic expression, defined
as a transferrin saturation ratio <35%. Indeed, body mass index (BMI) was a ... Cited by 9 - Related articles - All 18 versions
- ►eje.org CE Wrede, R Buettner, LC Bollheimer, J … - European journal of endocrinology, 2006 - eje.org Methods: The study subjects participated in a nationwide epidemiological survey
on metabolic disorders in the adult German population. The 1200 probands
included in this study are representative of the German population. To ... Cited by 39 - Related articles - BL Direct - All 9 versions
DJ Kudzma - American Journal of Managed Care, 2002 - ajmc.com Abstract The thiazolidinediones (TZDs) are a new class of oral antidiabetic
agents used in the treatment of type 2 diabetes mellitus. TZDs are selective and
potent agonists of peroxisome proliferator-activated receptor-gamma, which ... Cited by 17 - Related articles - View as HTML - BL Direct - All 5 versions
- ►diabetesjournals.org T Iwasaki, A Nakajima, M Yoneda, Y Yamada, … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 248 Japanese subjects (127 men and 121
postmenopausal women aged 57.8 ± 13.9 years, BMI 25.7 ± 4.6 kg/m 2 ; 140
subjects with type 2 diabetes and 108 nondiabetic subjects) were evaluated. ... Cited by 34 - Related articles - BL Direct - All 5 versions
F Wang, C Vergara, J Carabino, A Desilets, … - AMERICAN JOURNAL OF HEALTH SYSTEM …, 2004 - ASHP T hiazolidinediones are effective at achieving glycemic control in patients with
type 2 diabetes mellitus when used in combination therapy. However, this class
of insulin- sensitizing agents, which includes rosiglitazone maleate, ... Cited by 6 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org VR Aroda, RR Henry - Diabetes Spectrum, 2003 - Am Diabetes Assoc The thiazolidinediones are a unique class of oral antidiabetic agents that has
been shown to directly reduce insulin resistance at sites of insulin action,
specifically adipose tissue, skeletal muscle, and the liver. By reducing ... Cited by 7 - Related articles - BL Direct - All 2 versions
G Boden - Current Opinion in Endocrinology, Diabetes and …, 2004 - journals.lww.com Introduction The increase in obesity in the United States has reached epidemic
proportions [1]. As obesity is usually associated with an increase in insulin
resistance, it is not surprising that there has been an equally dramatic ... Cited by 8 - Related articles - BL Direct - All 2 versions
- ►partners.org [PDF] - Free from Publisher JB Meigs, K Williams, LM Sullivan, KJ Hunt, … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS — We assessed the capacity of the metabolic
syndrome (MetS) to identify IGT in a cross-sectional analysis of 3,326 Caucasian
Framingham Offspring Study (FOS), 1,168 Caucasian and 1,812 ... Cited by 47 - Related articles - BL Direct - All 6 versions
Y Aso, K Okumura, N Yoshida, K Tayama, Y … - Experimental and Clinical Endocrinology and Diabetes, 2004 - thieme-connect.com Impaired fibrinolysis in type 2 diabetes may be caused by an increased plasma
concentration of plasminogen activator inhibitor 1 (PAI-1), although the effects
of short-term hypoglycemic therapy on fibrinolytic activity are poorly ... Cited by 12 - Related articles - BL Direct - All 4 versions
